ATP6V1B2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.026300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.307420E-01
Normal-vs-Stage2
3.522400E-02
Normal-vs-Stage3
1.059580E-01
Normal-vs-Stage4
2.079600E-01
Stage1-vs-Stage2
9.607000E-01
Stage1-vs-Stage3
7.566000E-01
Stage1-vs-Stage4
8.783600E-01
Stage2-vs-Stage3
6.637000E-01
Stage2-vs-Stage4
8.703600E-01
Stage3-vs-Stage4
6.653600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.214500E-02
Normal-vs-AfricanAmerican
2.105600E-01
Normal-vs-Asian
1.424500E-02
Caucasian-vs-AfricanAmerican
9.772200E-01
Caucasian-vs-Asian
1.975780E-01
AfricanAmerican-vs-Asian
3.698800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.152400E-02
Normal-vs-Female
5.544300E-02
Male-vs-Female
7.266200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.013800E-01
Normal-vs-Age(41-60Yrs)
1.111180E-01
Normal-vs-Age(61-80Yrs)
6.789600E-02
Normal-vs-Age(81-100Yrs)
9.867500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.951600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.650000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.934600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.196980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.230800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.544700E-03
Normal-vs-Daily Drinker
1.534450E-02
Normal-vs-Weekly Drinker
9.636500E-02
Normal-vs-Occasional Drinker
8.601800E-02
Normal-vs-Social Drinker
1.677630E-01
Non Drinker-vs-Daily Drinker
9.241000E-01
Non Drinker-vs-Weekly Drinker
4.391800E-02
Non Drinker-vs-Occasional Drinker
1.558770E-01
Non Drinker-vs-Social Drinker
5.055500E-03
Daily Drinker-vs-Weekly Drinker
9.224300E-02
Daily Drinker-vs-Occasional Drinker
2.454200E-01
Daily Drinker-vs-Social Drinker
1.741600E-02
Weekly Drinker-vs-Occasional Drinker
6.212800E-01
Weekly Drinker-vs-Social Drinker
5.035200E-01
Occasional Drinker-vs-Social Drinker
2.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.210400E-01
Normal-vs-Grade 2
9.185800E-01
Normal-vs-Grade 3
9.078800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.020800E-01
Grade 1-vs-Grade 3
9.873000E-01
Grade 1-vs-Grade 4
8.210400E-01
Grade 2-vs-Grade 3
8.381200E-01
Grade 2-vs-Grade 4
9.185800E-01
Grade 3-vs-Grade 4
9.078800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.797600E-02
Normal-vs-NonDiabetic
4.833800E-02
Diabetic-vs-NonDiabetic
9.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.976600E-03
Normal-vs-NoPancreatitis
7.346000E-02
Pancreatitis-vs-NoPancreatitis
2.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.426250E-01
Normal-vs-N1
4.398100E-02
N0-vs-N1
7.751200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.626600E-04
Normal-vs-TP53-NonMutant
2.898000E-02
TP53-Mutant-vs-TP53-NonMutant
9.616000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
